HOSTT: Phase III study to evaluate the impact of maintaining haemoglobin levels above 120 g/L versus over 100 g/L in anaemic patients with carcinoma of the cervix receiving concurrent cisplatin and radiation therapy
Participants Women with previously untreated cancer of the cervix receiving concurrent cisplatin chemotherapy and radiation therapy